Thank You for
We appreciate you completing the ANDEMBRY survey.
Your responses help us tailor the information we provide.
Thanks again for your time and interest in ANDEMBRY.
Your responses help us tailor the information we provide.
Thanks again for your time and interest in ANDEMBRY.
ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.
It is not known if ANDEMBRY is safe and effective in children under 12 years of age.
Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.
Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.
Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.
ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.
The most common side effects of ANDEMBRY include:
Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.
The ANDEMBRY Mentor Program is available for patients or caregivers to connect with others who have personal experience with hereditary angioedema (HAE) and ANDEMBRY® (garadacimab-gxii).
Please enter the following information, which will be used as part of the verification process for enrollment.
Thank you for your interest in ANDEMBRY (garadacimab).
We have received your request and will begin sending you ANDEMBRY updates by email soon.
Thank you for your interest in ANDEMBRY (garadacimab).
We have received your request and will begin sending you ANDEMBRY updates by email soon.